DGAP-News

Asklepios Kliniken GmbH: Sustainable growth in first nine months of 2015

DGAP-News: Asklepios Kliniken GmbH / Key word(s): 9-month figures
Asklepios Kliniken GmbH: Sustainable growth in first nine months of 2015

26.11.2015 / 07:30
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Asklepios Kliniken GmbH: Sustainable growth in first nine months of 2015

- Placement of a promissory note loan of EUR 580 million

- Sales increase to more than EUR 2.3 billion

- EBITDA rises by around 13% to EUR 265 million

- Outlook confirmed: Organic sales growth in 2015 of between 2% and 4%

Hamburg, 26 November 2015. The Asklepios Group continued to grow in the
third quarter and over the first nine months of the year. In addition,
Asklepios took advantage of the favourable interest rate environment to
successfully place a promissory note loan of EUR 580 million.

Sales increased by 2.2% year-on-year to EUR 2,312.3 million in the period
from January to September (previous year: EUR 2,263.3 million). The main
reason for this was the increase in the number of both inpatients and, in
particular, outpatients. The hospitals and medical facilities cared for a
total of 1,723,270 patients in the reporting period.

"The growing number of patients proves that our strategy of specialised
clinics is the right one. Thanks to the highly specialised expertise of our
doctors and employees, we offer the best possible medical care at our
facilities, which are being sought out by more and more patients," said Dr
Ulrich Wandschneider, CEO of Asklepios Kliniken GmbH. "Overall we have
created a solid foundation from which to successfully tackle the challenges
of the Hospital Structure Act."

Lower rise in cost ratios increases consolidated net income

Operating EBITDA climbed by 12.9% to EUR 265.7 million in the first nine
months of 2015 (previous year: EUR 235.4 million). This resulted in an
EBITDA margin of 11.5% (previous year: 10.4%) and an increase of 1.1
percentage points. Cost items that increased at a lower rate than revenue
had a particularly positive effect.

The cost of materials ratio fell 0.4 percentage points year-on-year to
22.1% (previous year: 22.5%). This was mainly due to the significant
decline in energy expenses. The energy model established by Asklepios
throughout the Group and the supply of several hospitals with their own
combined heat and power units are continuously reducing expenses related to
energy. The staff costs ratio declined slightly by 0.6 percentage points to